Press Releases.
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
- November 01, 2016Conference Call Today at 5:00 p.m. ET
- October 25, 2016Conference Call and Webcast to Follow
- August 02, 2016Conference Call Today at 5:00 p.m. ET
- July 27, 2016On Track to Deliver Follow-up Results from On-going RG-101 Studies
- July 26, 2016Conference Call and Webcast to Follow
- June 27, 2016Timelines of On-going Studies are not Expected to be Impacted
- June 07, 2016- Results Demonstrate First Successful Shortened 4-week Treatment Regimen to Date -
- June 01, 2016- Phase II Study Evaluating the Combination of RG-101 and GSK's Long-Acting Parenteral (LAP) Formulation of GSK2878175 as a potential single-visit cure to begin Q4 2016
- April 15, 2016- Continued High Virologic Response Rates across All Treatment Arms Out through 24 weeks of Follow Up -
